Morningstar

GOSS Investor Alert: Gossamer Bio Securities Fraud Lawsuit - Investors With Losses May Seek to Lead the Class Action After CEO Allegedly Concealed PROSERA Placebo Risk: SueWallSt

NEW YORK, May 7, 2026 /PRNewswire/ -- SueWallSt alerts investors in Gossamer Bio, Inc. (NASDAQ: GOSS) of a pending securities class action naming senior leadership as individual defendants. Class ...
Morningstar

GOSS 4-DAY DEADLINE ALERT: Gossamer Bio Investors With Losses May Seek to Lead the Class Action After Executives Allegedly Concealed Placebo Risk: HBSS

SAN FRANCISCO, May 28, 2026 /PRNewswire/ -- A securities class action lawsuit has been filed against Gossamer Bio, Inc. (NASDAQ: GOSS) and an executive, seeking to represent investors who purchased or ...